TABLE 2.
Primers used in this study
| Primer name | Sequencea | Nucleotide recognition site (accession no.) |
|---|---|---|
| A start | 5′-gga tcc aaG GAG ATA CAT ATA TGA AAA AAT GGA-3′ | 1885–1909 (U32175) |
| rev A end | 5′-gtc gac TCG AAT GGC CAT CTT AGC ATC GAC-3′ | 5398–5421 (U32175) |
| 88R | 5′-aga tca aga tcT GCA ATG CAA GGT CGC CAA CAC-3′ | 2991–3010 (L23118) |
| 88BFD | 5′-aga tca aga tct CTG CCG CAC AGC TCC ATA GG-3′ | 4711–4730 (L23118) |
| 5′BlueMCS | 5′-gat gat cAG CGG ATA ACA ATT TCA CAC AGG-3′ | 827–846 (X52324) |
| 3′BlueMCS | 5′-gat gat cAC GCT TAC AAT TTC CAT TCG C-3′ | 451–470 (X52324) |
| NcoF | 5′-ATG CAA ATG GTA TAA AAG TTA G-3′ | 5077–5099 (U32175) |
| A end Sal | 5′-gtc gac CCA CTT ACA TCA ATC-3′ | 5576–5591 (U32175) |
Primer sequences homologous to the template are shown in capital letters, non-homologous sequences are in lowercase letters, and restriction sites incorporated into primers to facilitate the cloning of PCR products are underlined.